Rabies: Rare Human Infection - Common Questions

Infectious Disease Clinics of North America

Volumn 29, Issue 4, 2015, Pages 637-650

  Willoughby, Rodney E ^a  

^a Children's Hospital of Wisconsin   (United States)

Author keywords

Biopterin; Brain diseases; Diagnosis; Encephalitis; Lyssavirus; Mortality; Rabies; Therapy

Indexed keywords

RABIES IMMUNOGLOBULIN; RABIES VACCINE;

BLOOD ANALYSIS; BRAIN BIOPSY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); DIFFERENTIAL DIAGNOSIS; DOPPLER ECHOGRAPHY; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MEDICAL HISTORY; NEUROLOGICAL COMPLICATION; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; POST EXPOSURE PROPHYLAXIS; PROGNOSIS; RABIES; RABIES VIRUS; REVIEW; RISK FACTOR; SALIVA ANALYSIS; VIRUS DIAGNOSIS; VIRUS ENCEPHALITIS; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; BITES AND STINGS; PATHOGENICITY; PRE-EXPOSURE PROPHYLAXIS; RARE DISEASES; VIROLOGY;

ANIMALS; BITES AND STINGS; HUMANS; PRE-EXPOSURE PROPHYLAXIS; RABIES; RABIES VACCINES; RABIES VIRUS; RARE DISEASES;

EID: 84947862988     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2015.07.006     Document Type: Review

References (80)

1. Smith J.S., Fishbein D.B., Rupprecht C.E., et al. Unexplained rabies in three immigrants in the United States. A virologic investigation. N Engl J Med 1991, 324:205-211.
2. Hemachudha T., Ugolini G., Wacharapluesadee S., et al. Human rabies: neuropathogenesis, diagnosis, and management. Lancet Neurol 2013, 12:498-513.
3. Centers for Disease Control and Prevention (CDC) Human rabies - Kentucky/Indiana, 2009. MMWR Morb Mortal Wkly Rep 2010, 59:393-396.
4. Laothamatas J., Wacharapluesadee S., Lumlertdacha B., et al. Furious and paralytic rabies of canine origin: neuroimaging with virological and cytokine studies. J Neurovirol 2008, 14:119-129.
5. Hemachudha T., Sunsaneewitayakul B., Mitrabhakdi E., et al. Paralytic complications following intravenous rabies immune globulin treatment in a patient with furious rabies. Int J Infect Dis 2003, 7:76-77.
6. Lodmell D.L., Bell J.F., Moore G.J., et al. Comparative study of abortive and nonabortive rabies in mice. J Infect Dis 1969, 119:569-580.
7. Galelli A., Baloul L., Lafon M. Abortive rabies virus central nervous infection is controlled by T lymphocyte local recruitment and induction of apoptosis. J Neurovirol 2000, 6:359-372.
8. Caicedo Y., Paez A., Kuzmin I., et al. Virology, immunology and pathology of human rabies during treatment. Pediatr Infect Dis J 2015, 34:520-528.
9. Hunter M., Johnson N., Hedderwick S., et al. Immunovirological correlates in human rabies treated with therapeutic coma. J Med Virol 2010, 82:1255-1265.
10. Hooper D.C., Morimoto K., Bette M., et al. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol 1998, 72:3711-3719.
11. Holzmann-Pazgal G., Wanger A., Degaffe G., et al. Presumptive abortive human rabies - Texas, 2009. MMWR Morb Mortal Wkly Rep 2010, 59:185-190.
12. Rawat A.K., Rao S.K. Survival of a rabies patient. Indian Pediatr 2011, 48:574.
13. Karahocagil M.K., Akdeniz H., Aylan O., et al. Complete recovery from clinical rabies: case report. Turkiye Klinikleri Journal of Medical Science 2013, 33:547-552.
14. Phares T.W., Kean R.B., Mikheeva T., et al. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J Immunol 2006, 176:7666-7675.
15. Gilbert A.T., Petersen B.W., Recuenco S., et al. Evidence of rabies virus exposure among humans in the Peruvian Amazon. Am J Trop Med Hyg 2012, 87:206-215.
16. Follmann E.H., Ritter D.G., Beller M. Survey of fox trappers in northern Alaska for rabies antibody. Epidemiol Infect 1994, 113:137-141.
17. Orr P.H., Rubin M.R., Aoki F.Y. Naturally acquired serum rabies neutralizing antibody in a Canadian Inuit population. Arctic Med Res 1988, 47(Suppl 1):699-700.
18. Black D., Wiktor T.J. Survey of raccoon hunters for rabies antibody titers: pilot study. J Fla Med Assoc 1986, 73:517-520.
19. Wiedeman J., Plant J., Glaser C., et al. Recovery of a patient from clinical rabies-California, 2011. MMWR Morb Mortal Wkly Rep 2012, 61:61-65.
20. Murray K.O., Holmes K.C., Hanlon C.A. Rabies in vaccinated dogs and cats in the United States, 1997-2001. J Am Vet Med Assoc 2009, 235:691-695.
21. Noah D.L., Drenzek C.L., Smith J.S., et al. Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med 1998, 128:922-930.
22. Manning S.E., Rupprecht C.E., Fishbein D., et al. Human rabies prevention-United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2008, 57:1-28.
23. De Serres G., Skowronski D.M., Mimault P., et al. Bats in the Bedroom, Bats in the Belfry: reanalysis of the Rationale for Rabies Postexposure Prophylaxis. Clin Infect Dis 2009, 48:1493-1499.
24. Gable M.S., Gavali S., Radner A., et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 2009, 28:1421-1429.
25. Mallewa M., Vallely P., Faragher B., et al. Viral CNS infections in children from a malaria-endemic area of Malawi: a prospective cohort study. Lancet Glob Health 2013, 1:e153-e160.
26. Punja M., Pomerleau A.C., Devlin J.J., et al. Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: an etiology worth considering in the differential diagnosis of delirium. Clin Toxicol (Phila) 2013, 51:794-797.
27. Mattner F., Bitz F., Goedecke M., et al. Adverse effects of rabies pre- and postexposure prophylaxis in 290 health-care-workers exposed to a rabies infected organ donor or transplant recipients. Infection 2007, 35:219-224.
28. Lentz T.L., Wilson P.T., Hawrot E., et al. Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaremimetic neurotoxins. Science 1984, 226:847-848.
29. Boyer L.V., Theodorou A.A., Berg R.A., et al. Antivenom for critically ill children with neurotoxicity from scorpion stings. N Engl J Med 2009, 360:2090-2098.
30. Srinivasan A., Burton E.C., Kuehnert M.J., et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005, 352:1103-1111.
31. Maier T., Schwarting A., Mauer D., et al. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis 2010, 50:1112-1119.
32. Vora N.M., Basavaraju S.V., Feldman K.A., et al. Raccoon rabies virus variant transmission through solid organ transplantation. JAMA 2013, 310:398-407.
33. Laothamatas J., Hemachudha T., Mitrabhakdi E., et al. MR imaging in human rabies. AJNR Am J Neuroradiol 2003, 24:1102-1109.
34. Anderson L.J., Nicholson K.G., Tauxe R.V., et al. Human rabies in the United States, 1960 to 1979: epidemiology, diagnosis, and prevention. Ann Intern Med 1984, 100:728-735.
35. Powers C.N., Peavy D.L., Knight V. Selective inhibition of functional lymphocyte subpopulations by ribavirin. Antimicrob Agents Chemother 1982, 22:108-114.
36. O'Sullivan A., Willoughby R.E., Mishchuk D., et al. Metabolomics of cerebrospinal fluid from humans treated for rabies. J Proteome Res 2013, 12:481-490.
37. Rupprecht C.E., Gibbons R.V. Clinical practice. Prophylaxis against rabies. N Engl J Med 2004, 351:2626-2635.
38. Hemachudha T., Mitrabhakdi E., Wilde H., et al. Additional reports of failure to respond to treatment after rabies exposure in Thailand. Clin Infect Dis 1999, 28:143-144.
39. Knobel D.L., Cleaveland S., Coleman P.G., et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 2005, 83:360-368.
40. Feder H.M., Petersen B.W., Robertson K.L., et al. Rabies: still a uniformly fatal disease? Historical occurrence, epidemiological trends, and paradigm shifts. Curr Infect Dis Rep 2012, 14:408-422.
41. Willoughby R.E. Rabies treatment protocol and registry 2013, Medical College of Wisconsin and Children's Hospital of Wisconsin, Milwaukee (WI), Available at:. http://www.mcw.edu/rabies.
42. Rupprecht C.E., Briggs D., Brown C.M., et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 2010, 59:1-9.
43. Warrell M.J. Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure. Travel Med Infect Dis 2012, 10:1-15.
44. Warrell M.J., White N.J., Looareesuwan S., et al. Failure of interferon alfa and tribavirin in rabies encephalitis. BMJ 1989, 299:830-833.
45. Dolman C.L., Charlton K.M. Massive necrosis of the brain in rabies. Can J Neurol Sci 1987, 14:162-165.
46. Gode G.R., Saksena R., Batra R.K., et al. Treatment of 54 clinically diagnosed rabies patients with two survivals. Indian J Med Res 1988, 88:564-566.
47. Jackson A.C. Current and future approaches to the therapy of human rabies. Antiviral Res 2013, 99:61-67.
48. de Souza A., Madhusudana S.N. Survival from rabies encephalitis. J Neurol Sci 2014, 339:8-14.
49. Karande S., Muranjan M., Mani R.S., et al. Atypical rabies encephalitis in a six-year-old boy: clinical, radiological, and laboratory findings. Int J Infect Dis 2015, 36:1-3.
50. Schankin C.J., Birnbaum T., Linn J., et al. A fatal encephalitis. Lancet 2005, 365:358.
51. Coen M., O'Sullivan M., Bubb W.A., et al. Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis. Clin Infect Dis 2005, 41:1582-1590.
52. Willoughby R.E., Roy-Burman A., Martin K.W., et al. Generalized cranial artery spasm in human rabies. Dev Biol (Basel) 2008, 131:367-375.
53. Willoughby R.E., Tieves K.S., Hoffman G.M., et al. Survival after treatment of rabies with induction of coma. N Engl J Med 2005, 352:2508-2514.
54. Reece J.F., Chawla S.K., Hiby A.R. Decline in human dog-bite cases during a street dog sterilisation programme in Jaipur, India. Vet Rec 2013, 172:473.
55. Fooks A.R., Koraka P., de Swart R.L., et al. Development of a multivalent paediatric human vaccine for rabies virus in combination with Measles-Mumps-Rubella (MMR). Vaccine 2014, 32:2020-2021.
56. Malerczyk C., Vakil H.B., Bender W. Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV). Hum Vaccin Immunother 2013, 9:1454-1459.
57. Shanbag P., Shah N., Kulkarni M., et al. Protecting Indian Schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV). Hum Vaccin 2008, 4:365-369.
58. Sabchareon A., Chantavanich P., Pasuralertsakul S., et al. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine. Pediatr Infect Dis J 1998, 17:1001-1007.
59. Lang J., Duong G.H., Nguyen V.G., et al. Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants. Lancet 1997, 349:1663-1665.
60. Bejon P., Lusingu J., Olotu A., et al. Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med 2008, 359:2521-2532.
61. Nagarajan T., Rupprecht C.E., Dessain S.K., et al. Human monoclonal antibody and vaccine approaches to prevent human rabies. Curr Top Microbiol Immunol 2008, 317:67-101.
62. Ravish H.S., Srikanth J., Ashwath Narayana D.H., et al. Pre-exposure prophylaxis against rabies in children: safety of purified chick embryo cell rabies vaccine (Vaxirab N) when administered by intradermal route. Hum Vaccin Immunother 2013, 9:1910-1913.
63. Saxena S., Sonwane A.A., Dahiya S.S., et al. Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein. Vet Microbiol 2009, 136:36-44.
64. Li R., Huang L., Li J., et al. A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab(R) when administered according to a post-exposure regimen in healthy children and adults in China. Vaccine 2013, 31:5940-5947.
65. Zhou M., Zhang G., Ren G., et al. Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations. PLoS One 2013, 8:e63384.
66. Zhang S., Liu Y., Fooks A.R., et al. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies. Vaccine 2008, 26:345-350.
67. Koraka P., Bosch B.J., Cox M., et al. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice. Vaccine 2014, 32:4644-4650.
68. Both L., van D.C., Wright E., et al. Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans. FASEB J 2013, 27:2055-2065.
69. Gogtay N., Thatte U., Kshirsagar N., et al. Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: a randomized, dose-escalation phase 1 study in adults. Vaccine 2012, 30:7315-7320.
70. Kaku Y., Noguchi A., Hotta K., et al. Inhibition of rabies virus propagation in mouse neuroblastoma cells by an intrabody against the viral phosphoprotein. Antiviral Res 2011, 91:64-71.
71. Bakker A.B., Python C., Kissling C.J., et al. First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity. Vaccine 2008, 26:5922-5927.
72. Sloan S.E., Hanlon C., Weldon W., et al. Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates. Vaccine 2007, 25:2800-2810.
73. Wilde H., Wacharapluesadee S., Saraya A., et al. Human rabies prevention (comment from a canine-rabies-endemic region). J Travel Med 2013, 20:139-142.
74. Willoughby R.E., Opladen T., Maier T., et al. Tetrahydrobiopterin deficiency in human rabies. J Inherit Metab Dis 2008, 32:65-72.
75. Wallace R.M., Gilbert A., Slate D., et al. Right place, wrong species: a 20-year review of rabies virus cross species transmission among terrestrial mammals in the United States. PLoS One 2014, 9:e107539.
76. Eidson M., Matthews S.D., Willsey A.L., et al. Rabies virus infection in a pet guinea pig and seven pet rabbits. J Am Vet Med Assoc 2005, 227:932-935. 918.
77. Robbins A., Eidson M., Keegan M., et al. Bat incidents at children's camps, New York State, 1998-2002. Emerg Infect Dis 2005, 11:302-305.
78. Mani R.S., Madhusudana S.N., Mahadevan A., et al. Utility of real-time Taqman PCR for antemortem and postmortem diagnosis of human rabies. J Med Virol 2014, 86:1804-1812.
79. Dacheux L., Reynes J.M., Buchy P., et al. A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis 2008, 47:1410-1417.
80. Hemachudha T., Wacharapluesadee S. Antemortem diagnosis of human rabies. Clin Infect Dis 2004, 39:1085-1086.